JP2007500126A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007500126A5 JP2007500126A5 JP2006521141A JP2006521141A JP2007500126A5 JP 2007500126 A5 JP2007500126 A5 JP 2007500126A5 JP 2006521141 A JP2006521141 A JP 2006521141A JP 2006521141 A JP2006521141 A JP 2006521141A JP 2007500126 A5 JP2007500126 A5 JP 2007500126A5
- Authority
- JP
- Japan
- Prior art keywords
- concentrate
- dialysis solution
- acidic
- solution
- dextrose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012141 concentrate Substances 0.000 claims 53
- 239000000385 dialysis solution Substances 0.000 claims 51
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 25
- 230000002378 acidificating effect Effects 0.000 claims 25
- 239000012928 buffer substance Substances 0.000 claims 22
- 239000008121 dextrose Substances 0.000 claims 22
- 238000000034 method Methods 0.000 claims 18
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims 14
- 229940001447 lactate Drugs 0.000 claims 14
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims 12
- 239000000243 solution Substances 0.000 claims 8
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims 6
- 239000003929 acidic solution Substances 0.000 claims 6
- 239000001110 calcium chloride Substances 0.000 claims 6
- 229960002713 calcium chloride Drugs 0.000 claims 6
- 229910001628 calcium chloride Inorganic materials 0.000 claims 6
- 229960002337 magnesium chloride Drugs 0.000 claims 6
- 229910001629 magnesium chloride Inorganic materials 0.000 claims 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 5
- 229960005069 calcium Drugs 0.000 claims 5
- 239000011575 calcium Substances 0.000 claims 5
- 229910052791 calcium Inorganic materials 0.000 claims 5
- 229960001031 glucose Drugs 0.000 claims 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 3
- 239000007857 degradation product Substances 0.000 claims 3
- 239000008103 glucose Substances 0.000 claims 3
- 229910052708 sodium Inorganic materials 0.000 claims 3
- 239000011734 sodium Substances 0.000 claims 3
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 2
- AIJULSRZWUXGPQ-UHFFFAOYSA-N Methylglyoxal Chemical compound CC(=O)C=O AIJULSRZWUXGPQ-UHFFFAOYSA-N 0.000 claims 2
- 238000000502 dialysis Methods 0.000 claims 2
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 claims 2
- 238000001802 infusion Methods 0.000 claims 2
- 239000011777 magnesium Substances 0.000 claims 2
- 229910052749 magnesium Inorganic materials 0.000 claims 2
- 229940091250 magnesium supplement Drugs 0.000 claims 2
- 239000011259 mixed solution Substances 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 239000001540 sodium lactate Substances 0.000 claims 2
- 229940005581 sodium lactate Drugs 0.000 claims 2
- 235000011088 sodium lactate Nutrition 0.000 claims 2
- 230000001954 sterilising effect Effects 0.000 claims 2
- -1 3-deoxyglucazone Chemical compound 0.000 claims 1
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 claims 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 claims 1
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 claims 1
- 229940052299 calcium chloride dihydrate Drugs 0.000 claims 1
- 229940015043 glyoxal Drugs 0.000 claims 1
- RJGBSYZFOCAGQY-UHFFFAOYSA-N hydroxymethylfurfural Natural products COC1=CC=C(C=O)O1 RJGBSYZFOCAGQY-UHFFFAOYSA-N 0.000 claims 1
- 229940050906 magnesium chloride hexahydrate Drugs 0.000 claims 1
- DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 210000004303 peritoneum Anatomy 0.000 claims 1
- 229940083542 sodium Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/628,065 US7053059B2 (en) | 2003-07-25 | 2003-07-25 | Dialysis solutions with reduced levels of glucose degradation products |
| PCT/US2004/022895 WO2005011631A1 (en) | 2003-07-25 | 2004-07-15 | Dialysis solutions with reduced levels of glucose degradation products |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007500126A JP2007500126A (ja) | 2007-01-11 |
| JP2007500126A5 true JP2007500126A5 (https=) | 2007-05-31 |
Family
ID=34080723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006521141A Pending JP2007500126A (ja) | 2003-07-25 | 2004-07-15 | グルコース分解産物のレベルが低下している透析溶液 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7053059B2 (https=) |
| EP (1) | EP1648410A1 (https=) |
| JP (1) | JP2007500126A (https=) |
| MX (1) | MXPA06000973A (https=) |
| WO (1) | WO2005011631A1 (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10155082B2 (en) | 2002-04-10 | 2018-12-18 | Baxter International Inc. | Enhanced signal detection for access disconnection systems |
| US7052480B2 (en) | 2002-04-10 | 2006-05-30 | Baxter International Inc. | Access disconnection systems and methods |
| US7022098B2 (en) | 2002-04-10 | 2006-04-04 | Baxter International Inc. | Access disconnection systems and methods |
| US20040254513A1 (en) * | 2002-04-10 | 2004-12-16 | Sherwin Shang | Conductive polymer materials and applications thereof including monitoring and providing effective therapy |
| US20070293441A1 (en) * | 2003-09-22 | 2007-12-20 | Baxter International Inc. | High-pressure sterilization to terminally sterilize pharmaceutical preparations and medical products |
| US20050276868A1 (en) * | 2004-06-10 | 2005-12-15 | Bart Degreve | Bicarbonate-based peritoneal dialysis solutions |
| US7384558B2 (en) * | 2004-07-26 | 2008-06-10 | Baxter International Inc. | Compositions capable of inhibiting reactive oxygen and carbonyl species |
| US7935070B2 (en) | 2005-01-28 | 2011-05-03 | Fresenius Medical Care North America | Systems and methods for dextrose containing peritoneal dialysis (PD) solutions with neutral pH and reduced glucose degradation product |
| WO2006115067A1 (ja) * | 2005-04-20 | 2006-11-02 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 腹膜透析液 |
| US8133194B2 (en) * | 2006-02-22 | 2012-03-13 | Henry Ford Health System | System and method for delivery of regional citrate anticoagulation to extracorporeal blood circuits |
| US8211048B2 (en) * | 2006-02-22 | 2012-07-03 | Henry Ford Health System | System and method for delivery of regional citrate anticoagulation to extracorporeal blood circuits |
| JP4004523B1 (ja) * | 2006-04-21 | 2007-11-07 | 株式会社日本トリム | 透析液調製用水およびそれを用いた透析液、透析液の製造方法ならびに透析装置 |
| FR2925341A1 (fr) * | 2007-12-20 | 2009-06-26 | Gambro Lundia Ab | Appareil pour le traitement extracorporel de sang ou plasma recevant plusieurs articles a usage unique |
| US20090214807A1 (en) | 2008-02-27 | 2009-08-27 | Shawn Davis | Peelable seals including porous inserts |
| US8114043B2 (en) | 2008-07-25 | 2012-02-14 | Baxter International Inc. | Electromagnetic induction access disconnect sensor |
| US9585810B2 (en) | 2010-10-14 | 2017-03-07 | Fresenius Medical Care Holdings, Inc. | Systems and methods for delivery of peritoneal dialysis (PD) solutions with integrated inter-chamber diffuser |
| US9861733B2 (en) | 2012-03-23 | 2018-01-09 | Nxstage Medical Inc. | Peritoneal dialysis systems, devices, and methods |
| EP2688602B1 (en) | 2011-03-23 | 2019-11-06 | NxStage Medical, Inc. | Peritoneal dialysis systems, devices, and methods |
| AU2012272483B2 (en) | 2011-06-24 | 2016-06-16 | Lo, Richard W. C. | Multi-container systems and uses thereof |
| EP3482786B1 (en) * | 2012-03-23 | 2023-12-13 | NxStage Medical, Inc. | Peritoneal dialysis systems and devices |
| CN103006555B (zh) * | 2013-01-05 | 2014-08-06 | 四川美大康佳乐药业有限公司 | 一种羟乙基淀粉注射液及其制备方法 |
| US10518014B2 (en) * | 2015-10-30 | 2019-12-31 | Nxstage Medical, Inc. | Treatment fluid devices methods and systems |
| JP7032321B2 (ja) | 2016-05-06 | 2022-03-08 | ガンブロ・ルンディア・エービー | 配分液体用システム |
| WO2017191302A1 (en) | 2016-05-06 | 2017-11-09 | Gambro Lundia Ab | Dialysis concentrate |
| SG11201910175RA (en) * | 2017-05-05 | 2019-11-28 | Fresenius Medical Care Deutschland Gmbh | Peritoneal dialysis concentrate, peritoneal dialysis bag and set for continuous ambulatory peritoneal dialysis or automated peritoneal dialysis |
| WO2018237375A1 (en) | 2017-06-24 | 2018-12-27 | Nxstage Medical, Inc. | Peritoneal dialysis fluid preparation and/or treatment devices methods and systems |
| US20190262526A1 (en) | 2018-02-28 | 2019-08-29 | Nxstage Medical, Inc. | Fluid Preparation and Treatment Devices Methods and Systems |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4879280A (en) | 1981-09-24 | 1989-11-07 | Fresenius Ag | Dialysis solution for use in intraperitoneal dialysis |
| EP0076355A3 (en) | 1981-10-01 | 1983-05-25 | Abbott Laboratories | Improved peritoneal dialysis solution |
| GB8404299D0 (en) | 1984-02-18 | 1984-03-21 | Milner Research Ireland Ltd | Peritoneal dialysis |
| GB8300718D0 (en) | 1983-01-12 | 1983-02-16 | Milner Research Ireland Ltd | Glucose polymer solutions |
| US4886789A (en) | 1983-01-12 | 1989-12-12 | M. L. Laboratories Plc | Peritoneal dialysis and compositions for use therein |
| US6077836A (en) | 1983-01-12 | 2000-06-20 | Ml Laboratotries, Plc | Peritoneal dialysis and compositions for use therein |
| US4604379A (en) | 1984-06-18 | 1986-08-05 | Curators Of The University Of Missouri | Dialysis solutions containing cross-linked gelatin |
| JPS61502943A (ja) | 1984-06-22 | 1986-12-18 | ビ−チ、リチャ−ド・エル | 電解質溶液およびその生体内における使用 |
| DE3428201A1 (de) | 1984-07-31 | 1986-02-06 | Laevosan-Gesellschaft mbH & Co. KG, Linz | Loesungen fuer die peritonealdialyse |
| JPS61247466A (ja) | 1985-04-25 | 1986-11-04 | テルモ株式会社 | 腹膜透析用透析液 |
| DE3689863T2 (de) | 1985-06-22 | 1995-01-05 | Ml Lab Plc | In kontinuierlicher Peritonealdialyse verwendete Polymere. |
| GB8521712D0 (en) | 1985-08-31 | 1985-10-02 | Giltech Ltd | Solution for peritoneal dialysis |
| DE3683583D1 (de) | 1985-09-10 | 1992-03-05 | Res Corp Technologies Inc | Osmotische mittel fuer peritonealdialyse. |
| US4976683A (en) | 1986-06-20 | 1990-12-11 | Abbott Laboratories | Peritoneal dialysis method |
| GR870129B (en) | 1987-01-27 | 1987-02-04 | Giatzidis Ippokratis | Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis |
| DE3812525C1 (https=) | 1988-04-15 | 1989-06-22 | Fresenius Ag, 6380 Bad Homburg, De | |
| DE3821043A1 (de) | 1988-06-22 | 1989-12-28 | Fresenius Ag | Dialysier- und spuel-loesung zur intraperitonealen verabreichung |
| DE4123001A1 (de) | 1991-07-11 | 1993-01-14 | Laevosan Gmbh & Co Kg | Pharmazeutische zusammensetzung fuer die peritonealdialyse |
| SE9103395D0 (sv) | 1991-11-18 | 1991-11-18 | Gambro Ab | System med anvaendning av ensteril medicinsk loesning innehaallande glukos eller glukosliknande aemnen samt en loesning avsedd foer detta system |
| DE4242926C2 (de) | 1992-12-18 | 1994-12-15 | Fresenius Ag | Dialyselösung für die Peritonealdialyse |
| SG48090A1 (en) | 1993-01-19 | 1998-04-17 | Baxter Int | Multiple chamber container |
| US5436232A (en) | 1994-01-07 | 1995-07-25 | Laevosan-Gesellschaft Mbh | Pharmaceutical composition for peritoneal dialysis |
| JPH07252137A (ja) | 1994-02-21 | 1995-10-03 | Terumo Corp | 糖類含有電解質溶液 |
| GB9411009D0 (en) | 1994-06-02 | 1994-07-20 | Giltech Ltd | Dialysis fluid |
| SE510030C2 (sv) | 1995-08-08 | 1999-04-12 | Gambro Ab | Förfarande för blandning av steril medicinsk lösning samt behållare för utförande av förfarandet |
| CA2155910C (en) | 1995-08-11 | 1999-12-14 | George Wu | Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis |
| SE9600631D0 (sv) | 1996-02-20 | 1996-02-20 | Gambro Ab | Use of a solution comprising glucose for peritonial dialysis having reduced formation of AGE products |
| GB9714218D0 (en) | 1997-07-04 | 1997-09-10 | Allied Therapeutics Ltd | Peritoneal dialysis fluid |
| WO1999009953A1 (fr) | 1997-08-22 | 1999-03-04 | Shimizu Pharmaceutical Co., Ltd. | Preparation contenant du glucose |
| DE19748290B8 (de) | 1997-10-31 | 2009-09-03 | Fresenius Medical Care Deutschland Gmbh | Lösung für die Peritonealdialyse |
| DE69929550T8 (de) | 1998-05-21 | 2006-12-28 | Nipro Corp. | Albumin enthaltende Lösung für die Peritonealdialyse |
| DE69929555T8 (de) | 1998-06-17 | 2007-05-31 | Nipro Corp. | Verwendung einer Flüssigkeit zur Herstellung einer Dialyselösung für die kontinuierliche rezirkulierende Peritonealdialyse |
| SG72966A1 (en) * | 1998-07-08 | 2000-05-23 | Sumitomo Chemical Co | Transition metal compound olefin polymerization catalyst component olefin polymerization catalyst and process for producing olefin polymer |
| JP2000037452A (ja) | 1998-07-21 | 2000-02-08 | Terumo Corp | 腹膜透析液 |
| EG24303A (en) | 1998-10-20 | 2009-01-12 | Advanced Renal Technologies | Buffered compositions for dialysis |
| JP4284737B2 (ja) | 1999-02-26 | 2009-06-24 | 株式会社ジェイ・エム・エス | 中性腹膜透析液 |
| US6309673B1 (en) | 1999-09-10 | 2001-10-30 | Baxter International Inc. | Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy |
| JP4638106B2 (ja) | 1999-10-11 | 2011-02-23 | シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ | 医薬的使用のための溶液中における浸透圧剤としての、ｌ−カルニチンおよびそのアルカノイル誘導体の使用 |
| ATE311203T1 (de) | 1999-10-15 | 2005-12-15 | Dow Global Technologies Inc | Dialyselösung die polyglycol als osmotischen mittels enthält |
| US6787039B2 (en) | 2001-01-26 | 2004-09-07 | Degussa Ag | Amino acid composition for hemodialysis |
| JP2002282354A (ja) | 2001-03-27 | 2002-10-02 | Jms Co Ltd | 腹膜透析液 |
| GB0108359D0 (en) | 2001-04-03 | 2001-05-23 | Allied Therapeutics Ltd | Peritoneal dialysis fluid |
| EP1377594A4 (en) | 2001-04-10 | 2004-06-30 | Danisco Usa Inc | POLYMERIZATION OF MONO- AND DISACCHARIDES WITH MONOCARBOXYLIC ACIDS AND LACTONES |
| WO2003013553A1 (es) | 2001-08-10 | 2003-02-20 | Van Dyck Diaz Rodolfo Candelar | Fórmula de solución dialítica y procedimiento de diálisis gastrointestinal |
| DE10217356B4 (de) | 2002-04-18 | 2012-03-29 | Fresenius Medical Care Deutschland Gmbh | Lösung für die Peritonealdialyse |
-
2003
- 2003-07-25 US US10/628,065 patent/US7053059B2/en not_active Expired - Fee Related
-
2004
- 2004-07-15 EP EP04778412A patent/EP1648410A1/en not_active Ceased
- 2004-07-15 WO PCT/US2004/022895 patent/WO2005011631A1/en not_active Ceased
- 2004-07-15 JP JP2006521141A patent/JP2007500126A/ja active Pending
- 2004-07-15 MX MXPA06000973A patent/MXPA06000973A/es active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007500126A5 (https=) | ||
| JP5876042B2 (ja) | 透析前駆体組成物 | |
| CA2352561C (en) | Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy | |
| JP2008307404A (ja) | 透析療法のためのビカルボネートベースの溶液 | |
| JP5752791B2 (ja) | 透析酸前駆組成物 | |
| JP5690040B2 (ja) | 重炭酸塩ベースの腹膜透析溶液 | |
| CN103747789B (zh) | 透析前体组合物 | |
| JP5376480B1 (ja) | 酢酸及び酢酸塩を含む透析用ａ剤、及びそれを用いた２剤型透析用剤 | |
| JP5908352B2 (ja) | 医学的溶液、該医学的溶液の調製方法、及びその使用 | |
| CN103918960A (zh) | 一种果冻及其制备方法 | |
| CN109789213A (zh) | T4甲状腺激素的高稳定性包装解决方案 | |
| JPH08131542A (ja) | 腹膜透析液調製用溶液セット | |
| JP2013027383A (ja) | 食した後にマイナス水素イオンを産生する経口食品 | |
| JP2010042312A (ja) | 腹膜透析液調製用溶液セット | |
| JP2000051348A (ja) | 腹膜透析液 | |
| CN101843636B (zh) | 一种非pvc软袋包装血液滤过置换液的制备工艺及产品 | |
| CN101837010A (zh) | 一种非pvc软袋包装腹膜透析液的制备工艺及产品 | |
| JP2008119509A (ja) | 腹膜透析液調製用溶液セット | |
| JP4299501B2 (ja) | ヘパリンナトリウム注射液製剤 | |
| JP2006000482A (ja) | 生体適合性薬液製剤、その製造方法及びその保存方法 | |
| JP2004154558A (ja) | ろ過型人工腎臓用補液収容複室容器 | |
| CN103845358B (zh) | 包含羟乙基淀粉和含有碳酸氢根离子的电解质溶液的药物组合物 | |
| CN106606509A (zh) | 粉液碳酸氢盐腹膜透析液及其制备方法 | |
| JP4293742B2 (ja) | 透析用剤及びその製造方法 | |
| JP6216777B2 (ja) | 腹膜透析液 |